Characteristics | No. of patients | Percentage (%) | ||
---|---|---|---|---|
Age (years) | Mean±SD (years) | 43.1±16.6 | ||
Range | 8–71 | |||
Gender | Male | 22 | 46.8% | |
Female | 25 | 53.2% | ||
VAS score on admission | <6 | 20 | 42.6% | |
≥6 | 27 | 57.4% | ||
Tumor pathology | Benign bone tumors (n = 26) | Osteoid osteoma | 6 | 23.1% |
Osteoblastoma | 5 | 19.2% | ||
Enchondroma | 12 | 46.2% | ||
Osteofibrous dysplasia | 2 | 7.7% | ||
Nonossifying fibroma | 1 | 3.8% | ||
Malignant bone tumors (n = 21) | Bone metastases | 16 | 76.2% | |
Multiple myeloma | 5 | 23.8% | ||
Lesion location | Spine or sacrum | 15 | 31.9% | |
Upper extremity | 6 | 12.8% | ||
Lower extremity | 17 | 36.2% | ||
Pelvis | 9 | 19.1% | ||
Surgical management | MWA | 14 | 29.8% | |
MWA+BC | 18 | 38.3% | ||
Endoscopic MWA+IAB/BC | 15 | 31.9% | ||
Follow-up (months) | Mean±SD (months) | 4.8±1.6 | ||
Range | 2–9 |